Univariate and multivariate survival analysis showed that amplification and expression level of GATAD1 were independent predictors of poorer survival of glioma patients, which provided a strong rationale for focusing on GATAD1 in malignant glioma diagnosis and therapy. This evidence concerns the gene GATAD1 and glioma.